Ranked only against the same measurement, in the same unit. See the positive, neutral, opposite-direction and still-collecting evidence before deciding what is worth your own test.
Phoenix APOE4 Research · Reviewed by Kevin Tran, APOE4/4 carrier and founder · Data through 2026-08-23 · How to read this research
How to read this
Observational research: real APOE4 carriers tracked over time, each compared with their own earlier self. Members chose their interventions, with no randomisation or placebo group. Everything else they changed is shown beside each result.
Read the full methods and limitsFor APOE4 carriers, Phoenix has published positive evidence for Plain omega-3 against High-sensitivity C-reactive protein. Member #09CC01's High-sensitivity C-reactive protein moved from 1.2 to 0.2 mg/L in 139 days.
Phoenix has measured 1 intervention against High-sensitivity C-reactive protein: 1 positive. See the table below.
| Intervention | What we observed | Evidence status |
|---|---|---|
| Plain omega-3 | Member #09CC01's High-sensitivity C-reactive protein moved from 1.2 to 0.2 mg/L in 139 days. | Repeated positive |
Search by health goal or intervention to see what changed for real members, including results that moved the wrong way.
Inflammation · Lower inflammation · 1 intervention shown.
High-sensitivity C-reactive protein: Decrease 0.2–1 mg/L
Cases: 2Case range
Member #09CC01's High-sensitivity C-reactive protein moved from 1.2 to 0.2 mg/L in 139 days.
Plain omega-3
✓Repeated positiveMember #09CC01's High-sensitivity C-reactive protein moved from 1.2 to 0.2 mg/L in 139 days.
High-sensitivity C-reactive protein
Before1.2After0.2mg/L-83.3%
139 days between measurements
Promising early signal
What else changed: no nearby starts were recorded.
Next study: repeat High-sensitivity C-reactive protein after a dated Plain omega-3 window.
High-sensitivity C-reactive protein
Before1.9After1.7mg/L-10.5%
363 days between measurements
Full stack credited: Omega-3 (lead), Statin (undated).
What else changed: no nearby starts were recorded.
Next study: repeat High-sensitivity C-reactive protein after a dated Plain omega-3 window.
The 43-page study: what members tried, how their bloodwork and wearable results changed, and what else changed alongside them.
Turn evidence into your next test
476 members have already tried, measured and logged. Join Phoenix and your next blood draw joins the same Navigator you are reading.
Full research index
Choose an outcome, like LDL cholesterol or sleep, or an intervention, like training: both paths open the same measured records.